Progesterone-to-follicle index is better correlated with in vitro fertilization cycle outcome than blood progesterone level

Fertil Steril. 2015 Mar;103(3):669-74.e3. doi: 10.1016/j.fertnstert.2014.11.026. Epub 2014 Dec 24.

Abstract

Objective: To investigate the impact of late follicular phase progesterone (P) elevation in relation to ovarian response on cycle outcome.

Design: Cohort study. The progesterone-to-follicle index (PFI) was calculated by dividing the blood P by the number of follicles ≥14 mm. The clinical pregnancy rate was calculated against the range of PFI values and blood P levels.

Setting: In vitro fertilization unit.

Patient(s): A heterogenous population undergoing IVF with pituitary suppression and gonadotropin stimulation resulting in 3-15 follicles ≥14 mm and blood P≤10 nmol/L on hCG day and resulting in fresh embryo transfer.

Intervention(s): None.

Main outcome measure(s): Association of blood P and PFI with clinical pregnancy rate.

Result(s): Data were retrieved for 8,649 IVF cycles in normal responders. The (reverse) odd ratios for pregnancy were 1.112 (95% confidence interval [CI], 1.077-1.165) for blood P and 4.104 (95% CI, 3.188-5.284) for the PFI. Elevated P levels were associated with a lower pregnancy rate only when they reached the >93rd percentile. The PFI was inversely and linearly related to the pregnancy rate for the whole range of values.

Conclusion(s): A late increase in P level is detrimental if it is a consequence of increased P production per follicle (high PFI) but not if it is a consequence of additional follicular recruitment. The PFI enables clinicians to differentiate these conditions.

Keywords: IVF; follicle; progesterone; progesterone-to-follicle index.

MeSH terms

  • Adolescent
  • Adult
  • Female
  • Fertilization in Vitro / methods*
  • Health Status Indicators*
  • Humans
  • Infertility, Female / blood
  • Infertility, Female / diagnosis*
  • Infertility, Female / therapy*
  • Middle Aged
  • Ovarian Follicle / cytology*
  • Ovarian Reserve
  • Pregnancy
  • Progesterone / blood*
  • Prognosis
  • Treatment Outcome
  • Young Adult

Substances

  • Progesterone